← All organizations
Highest phase reached
Phase 4
First clinical trial
May 31, 2014Last known activity
Mar 1, 2026
Timeline
2010s
- Jun 1, 2010
Patient-Centered Outcomes Research Institute— Founded
Drugs by trial phase (62 distinct, 34 trials)
Phase 4 (43 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Agoraphobia
- Anxiety Disorders
- Bronchitis
- Bronchitis, Chronic
- Disease
- Fatigue
- Fractures, Bone
- Hip Fractures
- Lung Diseases
- Lung Diseases, Obstructive
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Panic Disorder
- Phobia, Social
- Pulmonary Disease, Chronic Obstructive
- Sclerosis
- Sleep Initiation and Maintenance Disorders
- Surgical Wound Infection
Recent trials (34)
- NCT07281027CollaboratorPhase 3Mar 1, 2026
- NCT07300956CollaboratorPhase 4Feb 28, 2026
- NCT07280468CollaboratorPhase 4Feb 1, 2026
- NCT07136415CollaboratorPhase 4Dec 1, 2025
- NCT07010302CollaboratorPhase 4Nov 30, 2025
- NCT06964464CollaboratorPhase 4Aug 17, 2025
- NCT06972056CollaboratorPhase 4Jul 9, 2025
- NCT06654882CollaboratorPhase 3Feb 28, 2025
- NCT06671002CollaboratorPhase 4Jan 31, 2025
- NCT06377852CollaboratorPhase 3Oct 29, 2024
- NCT06468202CollaboratorPhase 4Oct 18, 2024
- NCT06433635CollaboratorPhase 4Sep 1, 2024
- NCT06445946CollaboratorPhase 4Aug 1, 2024
- NCT06080698CollaboratorN/AJan 1, 2024
- NCT06076304CollaboratorPhase 4Dec 31, 2023
Details
- Founded
- Washington DC, Washington DC, US Jun 1, 2010
- Last known activity
- Mar 1, 2026